Ionis Reports Substantial Drop In Acute Pancreatitis Events With Cholesterol Lowering Drug

benzinga.com/news/health-care/25/11/48761735/ionis-reports-substantial-drop-in-acute-pancreatitis-events-with-cholesterol-lowering-drug

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on Sunday shared results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen for severe hypertriglyceridemia (sHTG), a condition characterized by dangerously high triglyceride (fat) levels.
IONS shares are retreating from recent levels.…

This story appeared on benzinga.com, 2025-11-10 18:37:16.
The Entire Business World on a Single Page. Free to Use →